D-0005-2021 Class II Terminated
FDA drug recall D-0005-2021 was initiated by PD-Rx Pharmaceuticals, Inc. on Sep 17, 2020 and is designated Class II. Reason for recall: CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent. The recall status is terminated (terminated Nov 5, 2021). Affected quantity: 20 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 14, 2020
- Initiation Date
- Sep 17, 2020
- Termination Date
- Nov 5, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 20 bottles
Product description
Nature-Throid 1 GR (65 mg), Each Tablet Contains: Thyroid USP 1 GR (65 mg), Liothyronine (T3) 9 mcg, Levothyroxine (T4) 38 mcg, 100 Tablets per bottle, Rx Only, Pkg By PD-Rx Pharmaceuticals Incorporated, Oklahoma City, OK 73127, NDC 43063-819-01.
Reason for recall
CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.
Distribution pattern
AZ, OK
Code information
Lot #: J18C68 Exp. 10/31/20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0005-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026